EE02983B1 - 4-[(2-bensiotiasolüül)metüülamino]-a-[(3,4-difluorofenoksü)metüül]-1-piperidiineta- nool, selle valmistamismeetod, soolad ja farmatseutilised kompositsioonid ning epoksüühend ja selle valmistamismeetod. - Google Patents

4-[(2-bensiotiasolüül)metüülamino]-a-[(3,4-difluorofenoksü)metüül]-1-piperidiineta- nool, selle valmistamismeetod, soolad ja farmatseutilised kompositsioonid ning epoksüühend ja selle valmistamismeetod.

Info

Publication number
EE02983B1
EE02983B1 EE9400339A EE9400339A EE02983B1 EE 02983 B1 EE02983 B1 EE 02983B1 EE 9400339 A EE9400339 A EE 9400339A EE 9400339 A EE9400339 A EE 9400339A EE 02983 B1 EE02983 B1 EE 02983B1
Authority
EE
Estonia
Prior art keywords
preparation
pharmaceutical compositions
salts
piperidinethanol
difluorophenoxy
Prior art date
Application number
EE9400339A
Other languages
English (en)
Estonian (et)
Inventor
Arthur Jules Grauwels Gilbert
Antoine Stokbroekx Raymond
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of EE02983B1 publication Critical patent/EE02983B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Paper (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
EE9400339A 1991-02-25 1994-11-21 4-[(2-bensiotiasolüül)metüülamino]-a-[(3,4-difluorofenoksü)metüül]-1-piperidiineta- nool, selle valmistamismeetod, soolad ja farmatseutilised kompositsioonid ning epoksüühend ja selle valmistamismeetod. EE02983B1 (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65964591A 1991-02-25 1991-02-25

Publications (1)

Publication Number Publication Date
EE02983B1 true EE02983B1 (et) 1997-04-15

Family

ID=24646210

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400339A EE02983B1 (et) 1991-02-25 1994-11-21 4-[(2-bensiotiasolüül)metüülamino]-a-[(3,4-difluorofenoksü)metüül]-1-piperidiineta- nool, selle valmistamismeetod, soolad ja farmatseutilised kompositsioonid ning epoksüühend ja selle valmistamismeetod.

Country Status (36)

Country Link
US (2) US5434168A (ja)
EP (2) EP0573473B1 (ja)
JP (1) JP2825652B2 (ja)
KR (1) KR0165901B1 (ja)
CN (3) CN1033454C (ja)
AT (1) ATE131478T1 (ja)
AU (1) AU649788B2 (ja)
BG (1) BG62332B1 (ja)
CA (1) CA2104000A1 (ja)
CY (1) CY1924A (ja)
CZ (1) CZ284705B6 (ja)
DE (1) DE69206787T2 (ja)
DK (1) DK0573473T3 (ja)
DZ (1) DZ1560A1 (ja)
EE (1) EE02983B1 (ja)
ES (1) ES2083737T3 (ja)
FI (1) FI933719A (ja)
GR (1) GR3018692T3 (ja)
HK (1) HK172296A (ja)
HU (2) HUT67695A (ja)
IE (1) IE69567B1 (ja)
IL (3) IL100952A (ja)
LV (1) LV11689B (ja)
MA (1) MA22447A1 (ja)
MX (1) MX9200777A (ja)
NO (1) NO300591B1 (ja)
NZ (2) NZ248437A (ja)
PL (1) PL168791B1 (ja)
RO (1) RO112959B1 (ja)
RU (2) RU2094434C1 (ja)
SK (1) SK278705B6 (ja)
TN (1) TNSN92017A1 (ja)
TW (1) TW218016B (ja)
WO (1) WO1992014731A1 (ja)
ZA (1) ZA921341B (ja)
ZW (1) ZW1992A1 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol
TW282469B (ja) * 1993-06-11 1996-08-01 Janssen Pharmaceutica Nv
NZ295132A (en) * 1994-10-14 1998-06-26 Janssen Pharmaceutica Nv Sabeluzole aqueous suspension having ph from 8 to 10
EP0794777A1 (en) * 1994-11-24 1997-09-17 Janssen Pharmaceutica N.V. Lubeluzole intravenous solutions
JPH10501823A (ja) * 1995-04-10 1998-02-17 バクスター、インターナショナル、インコーポレイテッド クモ膜下出血の治療における架橋ヘモグロビンの使用
IL123083A0 (en) * 1995-10-25 1998-09-24 Janssen Pharmaceutica Nv Lubeluzole n-oxides their preparation and pharmaceutical compositions containing them
US6025355A (en) 1997-05-19 2000-02-15 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
US6242198B1 (en) 1996-07-25 2001-06-05 Cambridge Neuroscience, Inc. Methods of treatment of eye trauma and disorders
US6756389B2 (en) 1996-08-09 2004-06-29 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
GB9815785D0 (en) * 1998-07-20 1998-09-16 Cerebrus Ltd Chemical compounds
ATE296814T1 (de) * 1999-05-12 2005-06-15 Neurosearch As Ionenkanal modulierende mittel

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3963732A (en) * 1973-05-30 1976-06-15 Tiberio Bruzzese Process for preparing dihydroxydiphenylmethane derivatives
US4310658A (en) * 1980-06-18 1982-01-12 Allied Corporation Production of polyester thermally stabilized with an oxirane
CA1260474A (en) * 1984-12-03 1989-09-26 Raymond A. Stokbroekx Benzoxazol- and benzothiazolamine derivatives
US4861785A (en) * 1984-12-03 1989-08-29 Janssen Pharmaceutica N.V. Benzoxazol-and benzothiazolamine derivatives, useful as anti-anoxic agents
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
US4689330A (en) * 1985-04-15 1987-08-25 Janssen Pharmaceutica N.V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4749702A (en) * 1985-04-15 1988-06-07 Janssen Pharmaceutica N. V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4717760A (en) * 1986-07-10 1988-01-05 The Dow Chemical Company Fluorinated tris-epoxides based on triphenyl methane
JPH0643426B2 (ja) * 1986-07-25 1994-06-08 東京田辺製薬株式会社 イミダゾ〔４，５−ｂ〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol

Also Published As

Publication number Publication date
MA22447A1 (fr) 1992-10-01
LV11689A (lv) 1997-02-20
RU2094434C1 (ru) 1997-10-27
JP2825652B2 (ja) 1998-11-18
ZA921341B (en) 1993-08-24
US5434168A (en) 1995-07-18
RO112959B1 (ro) 1998-02-27
CN1033454C (zh) 1996-12-04
SK278705B6 (sk) 1998-01-14
PL168791B1 (pl) 1996-04-30
IL100952A0 (en) 1992-11-15
EP0501552A1 (en) 1992-09-02
HUT67695A (en) 1995-04-28
RU95112519A (ru) 1997-04-20
ATE131478T1 (de) 1995-12-15
IL100952A (en) 1995-12-31
HK172296A (en) 1996-09-20
BG98068A (bg) 1994-06-30
CN1043609C (zh) 1999-06-16
NZ241592A (en) 1994-07-26
BG62332B1 (bg) 1999-08-31
CA2104000A1 (en) 1992-08-26
HU211560A9 (en) 1995-12-28
DZ1560A1 (fr) 2002-02-17
IE69567B1 (en) 1996-10-02
AU1208592A (en) 1992-09-15
NO933010D0 (no) 1993-08-24
IL113837A (en) 1996-05-14
FI933719A0 (fi) 1993-08-24
DE69206787D1 (de) 1996-01-25
IE920575A1 (en) 1992-08-26
DE69206787T2 (de) 1996-06-05
EP0573473A1 (en) 1993-12-15
NO300591B1 (no) 1997-06-23
IL113837A0 (en) 1995-08-31
TW218016B (ja) 1993-12-21
MX9200777A (es) 1992-08-01
ZW1992A1 (en) 1993-09-22
CN1064865A (zh) 1992-09-30
CN1113437A (zh) 1995-12-20
RU2106348C1 (ru) 1998-03-10
KR0165901B1 (en) 1999-01-15
EP0573473B1 (en) 1995-12-13
LV11689B (en) 1997-08-20
CS51292A3 (en) 1992-09-16
GR3018692T3 (en) 1996-04-30
JPH06505012A (ja) 1994-06-09
CY1924A (en) 1997-03-07
FI933719A (fi) 1993-08-24
CN1117048A (zh) 1996-02-21
US5675027A (en) 1997-10-07
WO1992014731A1 (en) 1992-09-03
NZ248437A (en) 1994-07-26
NO933010L (no) 1993-08-24
DK0573473T3 (da) 1996-01-29
CZ284705B6 (cs) 1999-02-17
HU9302395D0 (en) 1993-11-29
TNSN92017A1 (fr) 1993-06-08
AU649788B2 (en) 1994-06-02
ES2083737T3 (es) 1996-04-16

Similar Documents

Publication Publication Date Title
ATE126216T1 (de) Pyrazolderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.
TNSN90003A1 (fr) Derives de 2-aminopyrimidinones utiles notamment comme antagonistes des neurotransmetteurs et procede pour leur preparation
PT84218B (pt) Processo para a preparacao de 5,6-dihidro-2-(fenilo substituido)-1,2,4-triazina -3,5(2h,4h)-dionas e de composicoes farmaceuticas que as contem
EE02983B1 (et) 4-[(2-bensiotiasolüül)metüülamino]-a-[(3,4-difluorofenoksü)metüül]-1-piperidiineta- nool, selle valmistamismeetod, soolad ja farmatseutilised kompositsioonid ning epoksüühend ja selle valmistamismeetod.
PT95959A (pt) Processo para a preparacao de derivados de n-aril-piperazinoalcanamida e de composicoes farmaceuticas que os contem
RU93053624A (ru) 4-[(2-БЕНЗОТИАЗОЛИЛ)МЕТИЛАМИНО] -α- [(3,4-ДИФТОРОФЕНОКСИ)МЕТИЛ]-1-ПИПЕРИДИНЭТАНОЛ, СПОСОБ ЕГО ПОЛУЧЕНИЯ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ ЕЕ ПОЛУЧЕНИЯ
ES2045083T3 (es) Un procedimiento para preparar un compuesto quimico.
DE69017839D1 (de) NMDA-blockierende Verbindungen, pharmazeutische Präparate, deren Herstellung und Verwendung.
NZ233273A (en) Oxazole substituted normonyl compounds: pharmaceutical compositions, preparation and use thereof
AU4239089A (en) New 1,4-dihydropyridinederivative, namely (-)-2-{(2- aminoethoxy) ethoxy)-4-(2,3-dichlorophenyl)-3- ethoxycarbonyl-50methoxycarbonyl-6-methyl}-1,4- dihydropyridine, process for preparing it and pharmaceutical compositions containing it
NO178137C (no) Fremgangsmåte for fremstilling av et polyprenylholdig farmasöytisk preparat i form av harde kapsler
ATE109454T1 (de) Catecholaminester.
BR0202313A (pt) Compostos cìclicos de alfa-amino-gama-hidroxiamida, um processo para a preparação dos mesmos e composições farmacêuticas que contem os mesmos